Skip to Main Content

John Kiene Forrest, MD, BS

Associate Professor of Medicine (Cardiovascular Medicine); Director of Interventional Cardiology, Cardiovascular Medicine; Director of Structural Heart Disease, Yale Medicine; Director, Structural Heart Disease Program, Cardiovascular Medicine

Contact Information

John Kiene Forrest, MD, BS

Patient Care Location

Mailing Address

  • Cardiovascular Medicine

    PO Box 208017

    New Haven, CT, 06520-8017

    United States

Appointments

Education & Training

  • Fellowship
    Yale University School of Medicine (2012)
  • Fellowship
    Yale University (2010)
  • Residency
    Yale-New Haven Hospital/Traditional Program (2008)
  • Internship
    Yale-New Haven Hospital/Traditional Program (2006)
  • MD
    Yale University School of Medicine (2005)
  • BS
    Bowdoin College, History and Biochemistry (1998)

Activities

  • TAVR in Women and Bicuspids
    Virtual Meeting 2021
  • Update on Evolut Low Risk Trial
    Virtual Conference 2021
  • Management of Coronary Disease Pre-and Post TAVR: Guidelines, Tips and Tricks
    On-line Virtual Conference 2020
  • Primary Results of Evolut Low Risk Bicuspid Study
    Virtual Conference 2020
  • Critical Review of Evidence: TAVR in Low Risk Bicuspid Patients
    Virtual Conference 2020
    Society for Cardiovascular Angiography and Interventions Annual Meeting 2020
  • Blueprint for Bicuspid Treatment: TAVR Implant Strategies for Bicuspid Patients
    Virtual Conference 2020
  • TAVR Optimization Strategies in Complex Anatomies: Bicuspid
    Virtual Conference 2020
    Transcatheter Cardiovascular Therapeutics Annual Meeting 2020
  • Evolut Platform: Design Features, Outcomes, Implantation Tips and Tricks and Future Visions
    Virtual Conference 2020
  • Most Frequently Used TAVR Systems: An Update on Evolut
    Virtual Conference 2020
  • TAVR in Bicuspid Aortic Valves
    San Francisco, United States 2019
  • TAVR with High Risk for Coronary Obstruction
    San Francisco, United States 2019
  • TAVR Foundations for Fellows
    San Francisco, United States 2019
  • Latest Clinical Data in Bicuspid Disease
    Chicago, United States 2019
  • Valvular Heart Disease in 2019: A Field Transformed
    New Orleans, United States 2019
  • Transcatheter Therapies: Potential Realized
    New Orleans, United States 2019
  • New Technologies for Brain Protection During TAVR
    Las Vegas, United States 2019
  • Con: Cerebral Embolic Protection is a Niche Concept
    Las Vegas, United States 2019
  • TAVR in Patients with a Bicuspid Anatomy
    New York, United States 2019
  • Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Bicuspid Morphology: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
    Washington, United States 2019
  • Paravalvular Leak Post-TAVR
    San Diego, United States 2018
  • Cerebral Embolic Protection During TAVR
    San Diego, United States 2018
  • Coronary Obstruction After TAVR
    San Diego, United States 2018
  • The Road to Perdition: Severe Aortic Stenosis with Bicuspid Valve Disease
    San Diego, United States 2018
  • TAVR Foundations for Fellows
    San Diego, United States 2018
  • Structural Heart Disease in 2018: Moving from TAVR to TMVR and More
    Farmington, United States 2018
  • The Evolut PRO TAVR System: Confronting the Issues (Valve Sizing, New Pacemakers, Paravalvular Leak, and Extreme Calcification
    Chicago, United States 2018
  • Debate: Cerebral Embolic Protection Should be Used in All (Most) Cases
    Chicago, United States 2018
  • Challenging Structural Cases by the Experts: Predicting and Managing Coronary Obstruction during TAVR
    San Diego, United States 2018
  • TAVR Update: Evolut Pro Clinical Trials
    Miami, United States 2018
  • 30-Day Outcomes Following Transcatheter Aortic Valve Replacement with the Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT Registry
    San Diego, United States 2018
  • TAVR Shift to Intermediate-Risk Patients: Practical Considerations for the Heart Team and Hospitals
    Denver, United States 2017
  • Evolut R TAVR - Technology Review Including Evolut 34mm and PRO
    Denver, United States 2017
  • Ask the Experts - How Do I Manage These Challenge Case Scenarios?
    Chicago, United States 2017
  • Optimizing Post-Dilation with Self-Expanding Valves - Does Balloon Choice Matter?
    Chicago, United States 2017
  • Evolut R Snapshots I - The New Evolut R PRO System
    Chicago, United States 2017
  • Procedural Perfection: Ideal TAVR Using the Evolut - All the Tips and Tricks
    New Orleans, United States 2017
  • How to Build a Successful Multidisciplinary Interventional Program: Balancing Pressures of Good Practice and Good Research
    New Orleans, United States 2017
  • Will SURTAVI Change my Pratice: TAVI for Patients with Intermediate Risk?
    Paris, France 2017
  • Managing Complex Paravalvular Leaks
    Atlanta, United States 2017
  • Next Generation TAVI Technologies
    Prague, Czech Republic 2017
  • How to Mitigate the Risk of PVL post TAVR
    Prague, Czech Republic 2017
  • Low Incidence of Paravalvular Leak at 6 Months with the New Self-Expanding Repositionable Transcatheter Aortic Valve with Pericardial Wrap
    Denver, United States 2017
  • Transcatheter Mitral Valve-in-Ring with Concomitant Para-Ring Leak Closure
    Paris, France 2017
  • Recorded Case: Transcatheter Aortic Valve Replacement using Evolut Pro Valve
    Paris, France 2017
  • 30-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO System
    Washington, United States 2017
  • All-Cause Mortality or Major Stroke by Valve Size After Self-Expanding Transcatheter Aortic Valve Replacement
    San Francisco, United States 2016
  • Complex Cases Using a Self-Expanding TAVR
    Atlanta, United States 2015
  • Current Status of TAVR with the Self-Expanding CoreValve System
    Atlanta, United States 2015
  • Debate: Is TAVR or SAVR More Appropriate for All Comers: Pro
    Atlanta, United States 2015
  • Transcatheter Aortic Valve Replacement in Women Versus Men: An Analysis of the CoreValve US Pivotal and Continued Access Trials
    San Francisco, United States 2015
  • US Perspective: Optimizing Patient Selection and Imaging for TAVR
    Washington, United States 2014
  • Transcatheter Aortic Valve Replacement 2014
    New London, United States 2014
  • Innovation: New Frontier in Implantable Therapies: Clinical Need, Regulatory Challenges, and Market Opportunities
    London, United Kingdom 2014
  • Treating Iliac, SFA, and Critical Limb Ischemia - Patient Screening, Prognosis, Treatment Options and Outcomes
    Medellín, Colombia 2014
  • A True Hybrid Case: Off-Pump CABG and TAVR (Direct Aortic Approach using a 31mm CoreValve) in Patient with Left Main Disease, Bicuspid Aortic Valve Stenosis, and Severe Thrombocytopenia
    Washington, United States 2014
  • Focus of TAVR: Program, Patient Selections, and Complications
    Medellín, Colombia 2013
  • Recorded Case: Retrograde RCA CTO via RV Marginal: The Beating Corsair
    Miami, United States 2012
  • Complex Carotid Stenting
    Orlando, United States 2011
  • Device Choices for Percutaneous Aortic Paravalvular Leak Closure
    Vancouver, Canada 2011
  • Evaluation of everolimus-eluting and paclitaxel eluting stents in patients with jailed side branches: two-year results from the SPIRIT IV trial
    Paris, France 2011

Honors & Recognition

AwardAwarding OrganizationDate
ACC Emerging Leadership FacultyAmerican College of Cardiology2019
Yale Advanced Emerging Leadership Program2017
Fellow of the American College of Cardiology2016
Yale-New Haven Hospital Nurses Choice Award2016
Fellow of the Society for Cardiovascular Angiography and Interventions2015

Professional Service

OrganizationRoleDate
Journal of the American Medical Association (JAMA)Reviewer2021 - Present
Journal of American College of Cardiology (JACC)Guest Editor2021 - Present
Journal of American College of Cardiology (JACC)Reviewer2020 - Present
Society for Cardiovascular Angiography and InterventionsAnnual Meeting2019 - Present
Transcatheter Cardiovascular TherapeuticsAbstract Selection Committee2019 - Present
Yale University School of MedicineMission Statement Committee2018 - 2019
JACC InterventionReviewer2018 - Present
Transcatheter Valve TherapiesAnnual meeting (late breaking clinical trials, cases, innovation, moderated posters) reviewer2018 - Present
American College of CardiologyAnnual session Abstract Selection Committee Aorta Valve Disease2018 - Present
American College of CardiologySTS/ACC TVT Risk Model2018 - Present
Yale University School of MedicineQuality Committee2017 - 2019
Yale-New Haven HospitalYale-New Haven Health System Quality Committee2017 - 2019
Yale University School of MedicineShock Team2017 - Present
Aorta JournalEditor2017 - Present
Transcatheter Cardiovascular TherapiesAnnual meeting Session Chair2017 - Present
Transcatheter Valve TherapiesAnnual meeting, Abstract Selection Committee2017 - Present
Transcatheter Valve TherapiesAnnual meeting Session Chair2017 - Present
American College of CardiologyTVT Dataset Update2017 - Present
Yale University School of MedicineHeart Care Team2016 - Present
Yale University School of MedicineYale Medical Leadership Council2015 - Present
Yale-New Haven HospitalYale-New Haven Patient Experience Committee2015 - Present
American Journal of Cardiology, Catheterization and Cardiovascular InterventionsReviewer2015 - Present
MedtronicMedtronic Fundamentals of TAVR Fellows Course Co-Director2015 - Present
EdwardsEdwards TAVR Fellows Course Co-Director2015 - Present
MedtronicMedtronic Advanced Users Evolut R Program Co-Chair2015 - Present
St. Thomas Day SchoolMember Board of Governor's Vice-Chair Board 2019-2021 Chairman Board 2021-present2015 - Present

Departments & Organizations